Stockreport

Compass Therapeutics Announces CEO Transition [Yahoo! Finance]

Compass Therapeutics, Inc.  (CMPX) 
PDF developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that its Board of Directors has appointed Thomas Schuetz, M.D., Ph.D [Read more]